Non-small Cell Lung Cancer with Ros1 Gene Rearrangement

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-12-30
Clinical Trial Update: Description of Neurocognitive and Psychiatric Disorders Associated With Targeted Therapies Used in the Treatment of Lung Cancers With ALK/ROS1 Fusion and Their Impact on Patients' Quality of Life: Construction of an Experimental Patient-researcher Collaborative Care and Research Pathway
This clinical trial update outlines a study examining neurocognitive and psychiatric side effects of ALK/ROS1-targeted therapies in metastat…